SCI Pharmtech, Inc. (TPE:4119)
Taiwan · Delayed Price · Currency is TWD 53.80
-0.80 (-1.47%)
Sep 8, 2026, 1:30 PM CST
SCI Pharmtech Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 83.05 | 60.63 | 582.38 | 942.06 | 166.83 | 332.23 |
Trading Asset Securities | 1.01 | 14.17 | 110.37 | 89 | 97.55 | 360.4 |
Cash & Short-Term Investments | 84.07 | 74.8 | 692.76 | 1,031 | 264.37 | 692.63 |
Cash Growth | -76.56% | -89.20% | -32.81% | 290.00% | -61.83% | 9.42% |
Accounts Receivable | 193.22 | 247.93 | 289.51 | 307.37 | 173.57 | 82.98 |
Other Receivables | 0.02 | 1.17 | - | 0.15 | 31.1 | 265.59 |
Receivables | 193.24 | 249.1 | 289.51 | 307.52 | 204.67 | 348.56 |
Inventory | 729.71 | 728.3 | 620.9 | 529.53 | 513.43 | 294.18 |
Other Current Assets | 56.11 | 38.23 | 57.22 | 85.13 | 59.93 | 61.93 |
Total Current Assets | 1,063 | 1,090 | 1,660 | 1,953 | 1,042 | 1,397 |
Property, Plant & Equipment | 5,155 | 5,137 | 4,803 | 3,912 | 3,194 | 2,100 |
Long-Term Investments | 240.13 | 187.05 | 237.52 | 241.62 | 208.04 | 124.97 |
Other Intangible Assets | 25.48 | 29.65 | 37.77 | 46.15 | 54.58 | 60.29 |
Long-Term Deferred Tax Assets | 161.56 | 161.56 | 143.82 | 153.28 | 167.25 | 241.55 |
Other Long-Term Assets | 280.01 | 281.26 | 318.06 | 384.69 | 294.11 | 265.64 |
Total Assets | 6,925 | 6,887 | 7,201 | 6,691 | 4,961 | 4,190 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 44.71 | 60.95 | 58.44 | 44.25 | 48.64 | 33.78 |
Accrued Expenses | 41.68 | 60.3 | 99.04 | 110.72 | 128.35 | 121.46 |
Short-Term Debt | 315.5 | 318.6 | 0.1 | 175 | 112 | - |
Current Portion of Long-Term Debt | 122.9 | 360.11 | 403.44 | 20 | - | - |
Current Portion of Leases | 5.7 | 5.62 | 2.47 | 1.95 | 0.83 | 1.58 |
Current Income Taxes Payable | 35.49 | 42.89 | 85.25 | 11.54 | 3.86 | - |
Current Unearned Revenue | 64.36 | 36.11 | 94.92 | 38.37 | 31.77 | 41.76 |
Other Current Liabilities | 218.3 | 151.79 | 270.73 | 168.07 | 444.86 | 549.35 |
Total Current Liabilities | 848.64 | 1,036 | 1,014 | 569.89 | 770.32 | 747.94 |
Long-Term Debt | 574.85 | 258.39 | 578.01 | 842.67 | 432.36 | - |
Long-Term Leases | 41.86 | 44.46 | 6.37 | 2.86 | 0.2 | 0.57 |
Long-Term Unearned Revenue | - | - | - | - | 4.11 | - |
Pension & Post-Retirement Benefits | 7.14 | 7.6 | 11.96 | 21.54 | 19.53 | 16.95 |
Long-Term Deferred Tax Liabilities | 104.52 | 104.52 | 104.45 | 146 | 103.81 | 103.81 |
Other Long-Term Liabilities | 38.05 | 41.02 | 8.68 | 7.84 | 1 | - |
Total Liabilities | 1,615 | 1,492 | 1,724 | 1,591 | 1,331 | 869.26 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 1,195 | 1,195 | 1,195 | 1,195 | 953.82 | 953.82 |
Additional Paid-In Capital | 2,245 | 2,235 | 2,235 | 2,234 | 1,357 | 1,348 |
Retained Earnings | 1,885 | 1,968 | 2,037 | 1,646 | 1,373 | 1,067 |
Comprehensive Income & Other | -15.35 | -3.44 | 10.07 | 25.46 | -54.73 | -48.93 |
Shareholders' Equity | 5,310 | 5,394 | 5,477 | 5,100 | 3,629 | 3,321 |
Total Liabilities & Equity | 6,925 | 6,887 | 7,201 | 6,691 | 4,961 | 4,190 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 1,061 | 987.18 | 990.39 | 1,042 | 545.38 | 2.16 |
Net Cash (Debt) | -976.75 | -912.39 | -297.63 | -11.42 | -281.01 | 690.48 |
Net Cash Growth | - | - | - | - | - | 9.52% |
Net Cash Per Share | -8.16 | -7.62 | -2.48 | -0.10 | -2.61 | 6.42 |
Filing Date Shares Outstanding | 119.51 | 119.51 | 119.51 | 119.51 | 107.3 | 107.3 |
Total Common Shares Outstanding | 119.51 | 119.51 | 119.51 | 119.51 | 107.3 | 107.3 |
Working Capital | 214.49 | 54.05 | 646.01 | 1,383 | 272.08 | 649.37 |
Book Value Per Share | 44.43 | 45.14 | 45.83 | 42.67 | 33.82 | 30.95 |
Tangible Book Value | 5,285 | 5,365 | 5,439 | 5,054 | 3,575 | 3,260 |
Tangible Book Value Per Share | 44.22 | 44.89 | 45.51 | 42.29 | 33.31 | 30.38 |
Land | 687.88 | 687.88 | 687.88 | 687.88 | 687.88 | 825.68 |
Buildings | 723.09 | 723.37 | 722.9 | 707 | 700.23 | 684.47 |
Machinery | 2,521 | 2,510 | 2,467 | 1,786 | 1,185 | 577.08 |
Construction In Progress | 2,549 | 2,452 | 1,965 | 1,565 | 1,323 | 633.3 |